Article Details

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Receives $37.56 Consensus Target Price from ...

Retrieved on: 2025-03-24 11:43:59

Tags for this article:

Click the tags to see associated articles and topics

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Receives $37.56 Consensus Target Price from .... View article details on hiswai:

Excerpt

Two Sigma Investments LP now owns 1,843,743 shares of the company's stock worth $21,498,000 after acquiring an additional 863,363 shares in the last ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo